DalsnaFinance › Analyst accuracy › JPMorgan › CRL target
JPMorgan upgrades Charles River Labs stock rating on bookings
JPMorgan upgraded Charles River Laboratories International (NYSE:CRL) to Overweight from Neutral on Thursday and raised its price target to $310 from $180.
A fact about what JPMorgan published, as reported by Investing.com, not a recommendation from Dalsna Finance; JPMorgan is not affiliated with this site.
Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.